Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/TX/Lubbock
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Lubbock, TX

Studies commonly pay $75 to $4,500 per completed study

109 clinical trials are currently recruiting participants within 30 miles of Lubbock. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

109studies recruiting
4+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Lubbock right now

Top 25 of 109 recruiting studies, sorted by proximity — each links to its official registry page

This Study Will Evaluate the Effectiveness of NTX-001, a Surgical Nerve Repair Product When Used in People With Upper Extremity Nerve Lacerations.

Peripheral Nerve Injury Upper Limb, Peripheral Nerve Injury (PNI) Phase 3 Interventional 98 participants sought
Texas Tech — Lubbock, Texas (2.1 mi) · Sponsor: Neuraptive Therapeutics Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06616025)

Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy

Radiation Retinopathy, Visual Impairment Phase 3 Interventional 600 participants sought
Texas Retina Associates — Lubbock, Texas (2.1 mi) · Sponsor: Jaeb Center for Health Research
See eligibility & contact on ClinicalTrials.gov (NCT05844982)

A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

Low Grade Astrocytoma, Low Grade Glioma Phase 3 Interventional 170 participants sought
Covenant Children's Hospital — Lubbock, Texas (2.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04166409)

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

Breast Cancer N/A Observational 1,800 participants sought
Joe Arrington Cancer Research & Treatment Center — Lubbock, Texas (2.1 mi) · Sponsor: Exact Sciences Corporation
See eligibility & contact on ClinicalTrials.gov (NCT06401421)

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Phase 1, Phase 2 Interventional 960 participants sought
Covenant Children's Hospital — Lubbock, Texas (2.1 mi) · Sponsor: PedAL BCU, LLC
See eligibility & contact on ClinicalTrials.gov (NCT04726241)

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

High Grade Osteosarcoma, Localized Osteosarcoma Phase 2, Phase 3 Interventional 1,122 participants sought
Covenant Children's Hospital — Lubbock, Texas (2.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05691478)

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Melanoma Phase 3 Interventional 560 participants sought
Joe Arrington Cancer Research & Treatment Center — Lubbock, Texas (2.1 mi) · Sponsor: Regeneron Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06246916)

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer Phase 3 Interventional 1,160 participants sought
Research Site — Lubbock, Texas (2.1 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06692738)

EEG-Guided Binaural Beat Audio to Reduce Performance-Related Stress and Improve Cognition

Cognitive Abilities, Performance N/A Interventional 32 participants sought
Texas Tech University — Lubbock, Texas (2.1 mi) · Sponsor: Texas Tech University Health Sciences Center
See eligibility & contact on ClinicalTrials.gov (NCT07407426)

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought
Covenant Medical Center-Lakeside — Lubbock, Texas (2.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT01810913)

Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia

Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma Phase 2 Interventional 80 participants sought
Covenant Children's Hospital — Lubbock, Texas (2.1 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT02981628)

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

Moderately to Severely Active Crohns Disease Phase 3 Interventional 425 participants sought
Texas Digestive Disease Consultants-Lubbock powered by GI Alliance — Lubbock, Texas (2.1 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT06819891)

Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response

Arthritis, Psoriatic Phase 3 Interventional 600 participants sought
Clinical Site — Lubbock, Texas (2.1 mi) · Sponsor: MoonLake Immunotherapeutics AG
See eligibility & contact on ClinicalTrials.gov (NCT06641089)

Evaluating the Efficacy of Blood Flow Restriction Therapy in a Randomized Clinical Trial for Postoperative Rehabilitation Following Ankle Ligament Reconstruction

Ankle Reconstruction, Blood Flow Restriction Therapy N/A Interventional 105 participants sought
Physical Therapy Today (PTT) — Lubbock, Texas (2.1 mi) · Sponsor: Texas Tech University Health Sciences Center
See eligibility & contact on ClinicalTrials.gov (NCT07451210)

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia Phase 2 Interventional 461 participants sought
Covenant Children's Hospital — Lubbock, Texas (2.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04546399)

Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR

Proliferative Diabetic Retinopathy (PDR) Phase 3 Interventional 426 participants sought
Texas Retina Associates — Lubbock, Texas (2.1 mi) · Sponsor: Jaeb Center for Health Research
See eligibility & contact on ClinicalTrials.gov (NCT06790784)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Ganglioneuroblastoma, Nodular, Neuroblastoma Phase 3 Interventional 478 participants sought
Covenant Children's Hospital — Lubbock, Texas (2.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06172296)

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Ulcerative Colitis Phase 3 Interventional 751 participants sought
GI Alliance - Lubbock - Site Number: 8400092 — Lubbock, Texas (2.1 mi) · Sponsor: Sanofi
See eligibility & contact on ClinicalTrials.gov (NCT07185009)

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

Metastatic Clear Cell Renal Cell Carcinoma, Advanced Clear Cell Renal Cell Carcinoma Phase 3 Interventional 720 participants sought
Research Site — Lubbock, Texas (2.1 mi) · Sponsor: Arcus Biosciences, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07011719)

Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma

Childhood Astrocytoma, Childhood Diffuse Intrinsic Pontine Glioma Phase 1 Interventional 54 participants sought
UMC Cancer Center / UMC Health System — Lubbock, Texas (2.1 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT06894979)
Actively enrolling

Studies you may be able to join near Lubbock

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Lubbock

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Texas Tech Physicians Internal Medicine Clinic

★ 4.9
3601 4th St, Lubbock, TX 79430
(806) 743-3150
"Dr Test is one of the nicest, most personable doctors that i have met in a long time."
— Rena Mashburn, 5★

Department of Internal Medicine Texas Tech University Health Sciences Center

★ 3.7
3601 4th St, Lubbock, TX 79430
(806) 743-3155
"If you don't see the little sign behind a large pillar that denotes where the line starts, and innocently stand in the wrong place, the much older, r…"
— Dan Hammons, 1★

Texas Tech University Health Sciences Center

Lubbock, TX 79415

Texas Tech Physicians: Dermatology

★ 4.9
Texas Tech University, Physicians Medical Pavilion, 3601 4th St 4th Floor, Lubbock, TX 79430
(806) 743-1842
"Dr. Alba Posligua, M.D., in the Texas Tech Physicians Dermatology Clinic provides ***EXCEPTIONAL*** quality care.<br><br>All of the staff were extrem…"
— Kelvin Meeks, 5★

Clinical trials in Lubbock: what's recruiting

The Lubbock area currently has 109 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Lubbock, the most active research areas are:

  • Cancer & Oncology14 studies
  • Immune & Skin4 studies
  • Liver & Kidney2 studies
  • Diabetes & Metabolism1 studies

Every listing shows the study phase, the recruiting site and its distance from Lubbock, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Lubbock

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Lubbock participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Lubbock?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
How do I join a study in Lubbock, TX?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in Lubbock?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Lubbock?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Lubbock.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Lubbock typically complete one or two studies per year.

Paid clinical trials near Lubbock

Other metros within reach

Midland, TX18 Amarillo, TX99 Odessa, TX18 Fort Worth, TX609 Denton, TX379 Oklahoma City, OK635 Arlington, TX1,871 Killeen, TX105

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Lubbock Bladder Issues Due To Spinal Cord Injury in Lubbock All conditions

More of TX

Houston3,069 Pasadena3,010 Irving1,988 Grand Prairie1,956 Arlington1,871 Dallas1,868 Garland1,830 Plano1,825 Frisco1,824 Mesquite1,771 San Antonio1,010 Austin738

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts